NICE Bipolar disorder in adolescents – aripiprazole TA292
Aripiprazole (Abilify) is a licensed treatment for moderate to severe manic episodes in young people aged 13+ with bipolar 1 disorder. Other antipsychotics, such as quetiapine and risperidone, [...]